AMGEN 20/25AMGEN 20/25AMGEN 20/25

AMGEN 20/25

No trades
See on Supercharts

AMGB analysis



Key facts


Issue date
Feb 21, 2020
Maturity date
Feb 21, 2025
Outstanding amount
‪500.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
1.90% (Fixed)
Yield to maturity
5.51%
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.